Print pageHome » US Court Tentatively Approves Bristol-Myers Squibb's $125-million Settlement in Plavix Lawsuit
US Court Tentatively Approves Bristol-Myers Squibb's $125-million Settlement in Plavix Lawsuit
FirstWordPlus.com
PharmaManufacturing.com
08/19/2009
A US court granted preliminary approval to a $125-million settlement reached in a shareholder lawsuit against Bristol-Myers Squibb regarding the company's attempts to resolve a patent dispute with Apotex over Plavix (clopidogrel), according to court documents.
In the shareholder complaint, investors alleged that Bristol-Myers Squibb did not disclose that it had agreed to relinquish certain legal rights in the 2006 agreement with Apotex that aimed to keep the Canadian drugmaker from launching generic versions of the anticoagulant until September 2011. The plaintiffs also claimed that the company had entered into "secret" oral side agreements with the Canadian generic drugmaker, and that the agreements limited Bristol-Myers Squibb's ability to recover damages and enforce its patent rights.
To read more, click here.
More News:
- 09/02/2010 SEC Nabs Merck Exec for Insider TradingFrom NYPost.com
- 09/02/2010 PBS: Behind FDA's Resource ChallengeFrom PBS.org
- 08/30/2010 Sanofi CEO: Genzyme is 'Stonewalling'From TheStreet.com
- 08/26/2010 115 Employees at Pfizer Will Lose Jobs in DecemberFrom RecordOnline.com
- 08/26/2010 Mexican Drug Gangs Target Pharma ShipmentsFrom SecuringPharma.com
- 08/26/2010 Lilly Manufacturing Facility Shutting Down, 140 People AffectedFrom MyCentralJersey.com
- 08/25/2010 Rockwell Automation Releases FactoryTalk Pharma Suite 2.1 Software
- 08/24/2010 Recall Fallout: FDA Puts Execs On NoticeFrom Money.CNN.com
- 08/19/2010 Dumped in a Parking Lot: How Pfizer Fires Sales Reps It Doesn't LikeFrom BNet.com
- 08/19/2010 Pharma's Contraction Leads to Outsourcing HiresFrom Portfolio.com
- All news »
Get Connected Now!
- Featured White Papers
Sponsored Links
